Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohortBarry J. Byrne, Raymond Wang, Nancy D. Leslie et al.|Cardiology in the Young|2021Cited by 15
Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfaJames Davison, Xianzhang Meng, Anaïs Brassier et al.|Molecular Genetics and Metabolism|2021Cited by 1
Mini-COMET study: Individual participant-level responses to treatment in patients with infantile-onset Pompe disease receiving repeated dose regimens of avalglucosidase alfa or alglucosidase alfa who were previously treated with alglucosidase alfaPriya S. Kishnani, David Kronn, Anaïs Brassier et al.|Molecular Genetics and Metabolism|2021Cited by 1
Mini-COMET: Individual-level treatment responses in infantile-onset Pompe disease participants receiving avalglucosidase alfa or alglucosidase alfa who previously received alglucosidase alfaPriya S. Kishnani, David Kronn, Alexander Broomfield et al.|Molecular Genetics and Metabolism|2021Cited by 1
Mini-COMET study: Safety, immunogenicity, and preliminary efficacy for repeat avalglucosidase alfa dosing in patients with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa and demonstrated clinical declineDavid Kronn, Judith Johnson, Anaïs Brassier et al.|Molecular Genetics and Metabolism|2020Cited by 0